Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/cas.13352 http://scihub22266oqcxt.onion/10.1111/cas.13352 C5665759!5665759!28796922     free     free     free       Cancer+Sci 2017 ; 108 (11): 2107-14 Nephropedia Template TP {{tp|p=28796922|t=2017. Long non?coding RNAs and prostate cancer |pdf=|usr=}}{{28796922}} gab.com Text Long non coding RNAs and prostate cancer JO: Cancer Sci http://www.kidney.de/pget.php?&tw=1&pmid=28796922 #FOAvip Long non?coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration?resistant prostate cancer. Twit Text FOAVip Long non coding RNAs and prostate cancer ????Cancer Sci http://www.kidney.de/pget.php?&tw=1&pmid=28796922 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28796922 #FOAvip English Wikipedia <ref>{{Cite pmid|28796922}}</ref> Long non?coding RNAs and prostate cancer #MMPMID28796922 Misawa A; Takayama K; Inoue S Cancer Sci 2017[Nov]; 108 (11): 2107-14 PMID28796922show ga Long non?coding RNAs (lncRNAs) are RNA transcripts larger than 200 nucleotides that do not code for proteins the aberrant expression of which has been documented in various types of cancer, including prostate cancer. Lack of appropriate sensitive and specific biomarkers for prostate cancer has led to overdiagnosis and overtreatment, making lncRNAs promising novel biomarkers as well as therapeutic targets for the disease. The present review attempts to summarize the current knowledge of lncRNA expression patterns and mechanisms in prostate cancer, which contribute to carcinogenesis. In particular, we focused on lncRNAs regulated by androgen receptor and expressed in castration?resistant prostate cancer. äLong non?coding RNAs and prostate cancer (epmc).pdf DeepDyve Pubget Overpricing